Skip to main content
Log in

Survey ofEscherichia coli septicemia over a six-year period

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Escherichia coli was the most frequent species isolated from blood cultures in the Hospital Covadonga of Oviedo (Spain) over a six-year period (474 episodes, 15.3 % of the total septicemias and 2.7 episodes per 1,000 patients).Escherichia coli strains were susceptible in >95 % of episodes to cefoxitin, cefotaxime, gentamicin, tobramicin and amikacin. In a series of 72 episodes, microbiological features and host factors were studied. No endemic strains were found. Type 1 fimbria was detected in 73.6% of strains and P-fimbriae in 12.5 %, without correlation between P-fimbria and urinary infection; 84.7 % of the strains were resistant to decomplement human serum; 61.1 % produced aerobactin and 20.8 % were hemolytic. Factors such as age, hospital location, metastatic focus and surgical treatment were significantly correlated with morbidity and mortality. The global mortality rate was 18 %, and in 8.3 % of cases was directly associated with septicemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sussman M:Escherichia coli in human and animal disease. In: Sussman M (ed): The virulence ofEscherichia coli. Reviews and methods. Academic Press, London, 1985, p. 7–45.

    Google Scholar 

  2. Fidalgo S, Vázquez F, Mendoza MC, Pérez F, Méndez FJ: Bacteremia due toStaphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features. Reviews of Infectious Diseases 1990, 12: 520–528.

    PubMed  Google Scholar 

  3. Kreger BE, Craven DE, Carling PC, McCabe WR: Gram-negative bacteremia. III: Reassessment of etiology, epidemiology and ecology in 612 patients. American Journal of Medicine 1980, 68: 332–343.

    Article  PubMed  Google Scholar 

  4. McGowan JE, Barnes MW, Finland M: Bacteremia at Boston city hospital: occurrence and mortality during 12 selected years (1935–1972), with special reference to hospital-acquired cases. Journal of Infectious Diseases 1975, 132: 316–335.

    PubMed  Google Scholar 

  5. Harris RL, Musher DM, Bloom K, Gathe J, Rice L, Sugarman B, Williams TW, Young EJ: Manifestations of sepsis. Archives of Internal Medicine 1987, 147: 1895–1906.

    Article  PubMed  Google Scholar 

  6. Grupo de estudio de la bacteriemia: Bacteriemia en seis hospitales españoles. Medicina Clínica 1986, 86: 221–232.

    Google Scholar 

  7. Ørskov F, Ørskov I: Serotyping ofEscherichia coli. In: Bergan T (ed): Methods in microbiology. Volume 14. Academic Press, London, 1984, p. 43–112.

    Google Scholar 

  8. Buckwold FJ, Ronald AR, Harding GKM, Marrie TJ, Fox L, Cates C: Biotyping ofEscherichia coli by a simple multiple-inoculation agar plate technique. Journal of Clinical Microbiology 1979, 10: 275–278.

    PubMed  Google Scholar 

  9. Bauer AW, Kirby WMM, Sherris JC, Turck M: Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology 1966, 45: 493–496.

    PubMed  Google Scholar 

  10. Amsterdam D: The new NCCLS susceptibility documents. Antimicrobial Newsletter 1989, 6: 1–8.

    Article  Google Scholar 

  11. Harnett NM, Gyles CL: Resistance to drugs and heavy metals, colicin production, and biochemical characteristics of selected bovine and porcineEscherichia coli strains. Applied Environmental Microbiology 1984, 48: 930–935.

    Google Scholar 

  12. Vázquez F, Fidalgo S, Méndez FJ, Mendoza MC: Resistance to antibiotics and inorganic ions in virulent bacterial strains from a hospital. Journal of Chemotherapy 1989, 1: 233–239.

    PubMed  Google Scholar 

  13. Birnboim HC, Doly J: A rapid alkaline extraction procedures for screening recombinant plasmid DNA. Nucleic Acids Research 1979, 7: 1513–1523.

    PubMed  Google Scholar 

  14. Marre R, Hacker J, Henkel W, Goebel W: Contribution of cloned virulence factors from uropathogenicEscherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model. Infection and Immunity 1986, 54: 761–767.

    PubMed  Google Scholar 

  15. Williams PH: Novel iron uptake system specified by Col V plasmids: an important component in the virulence of invasive strains ofEscherichia coli. Infection and Immunity 1979, 26: 925–932.

    PubMed  Google Scholar 

  16. Svenson SB, Källenius G, Möllby R, Hultberg H, Winberg J: Rapid identification of P-fimbriatedEscherichia coli by a receptor-specific particle agglutination test. Infection 1982, 10: 209–214.

    Article  PubMed  Google Scholar 

  17. Small PLC, Falkow S: Identification of regions on a 230-kilobase plasmid from enteroinvasiveEscherichia coli that are required for entry into HEp-2 cells. Infection and Immunity 1986, 56: 225–229.

    Google Scholar 

  18. Bhaduri S, Conway LK, Lachica RV: Assay of crystal violet binding for rapid identification of virulent plasmid-bearing clones ofYersinia enterocolitica. Journal of Clinical Microbiology 1987, 25: 1039–1042.

    PubMed  Google Scholar 

  19. Kandolo K, Wauters G: Pyrazinamidase activity inYersinia enterocolitica and related organisms. Journal of Clinical Microbiology 1985, 21: 980–982.

    PubMed  Google Scholar 

  20. Day NP, Scotland SM, Rowe B: Comparison of an HEp-2 tissue culture test with the Sereny test for detection of enteroinvasiveness inShigella spp. andEscherichia coli. Journal of Clinical Microbiology 1981, 13: 596–597.

    PubMed  Google Scholar 

  21. Montgomerie JZ, Bindereif A, Neilands JB, Kalmanson GM, Guze LB: Association of hydroxamate siderophore (aerobactin) withEscherichia coli isolated from patients with bacteremia. Infection and Immunity 1984, 46: 835–838.

    PubMed  Google Scholar 

  22. Carbonetti NH, Williams PH: Detection of synthesis of the hydroxamate siderophore aerobactin by pathogenic isolates ofEscherichia coli. In: Sussman N (ed): The virulence ofEscherichia coli. Academic Press, London, 1985, p. 419–423.

    Google Scholar 

  23. Bindereif A, Neilands JB: Aerobactin genes in clinical isolates ofEscherichia coli. Journal of Bacteriology 1985, 161: 727–735.

    PubMed  Google Scholar 

  24. Maniatis T, Fritsch EF, Sambrook J: Molecular cloning: a laboratory manual. Gold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1982.

    Google Scholar 

  25. Nordic Council on Medicines: Nordic statistics on medicines 1981–1983. II: Nordic drugs index with classification and defined daily doses. Uppsala, 1985.

  26. Hunter PR, Gaston MA: Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. Journal of Clinical Microbiology 1988, 26: 2465–2466.

    PubMed  Google Scholar 

  27. Filice GA, van Ettal LL, Darby CP, Fraser DW: Bacteremia in Charleston County, South Carolina. American Journal of Epidemiology 1985, 123: 128–136.

    Google Scholar 

  28. McCabe WR: Gram-negative bacteremia: a physician's overview. In: Sanford JP (ed): Gram-negative sepsis. Medeom, New York 1971, p. 165–178.

    Google Scholar 

  29. Gransden WR, Eykyn SJ, Phillips I, Rowe B: Bacteremia due toEscherichia coli: a study of 861 episodes. Reviews of Infectious Diseases 1990, 12: 1008–1018.

    PubMed  Google Scholar 

  30. Kreger BE, Craven DE, McCabe WR: Gram-negative bacteremia. IV. Reevaluation of clinical features and treatment in 612 patients. American Journal of Medicine 1980, 68: 344–345.

    Article  PubMed  Google Scholar 

  31. Brauner A, Leissner M, Wretlind B, Julander I, Svenson SB, Källenius G: Occurrence of P-fimbriatedEscherichia coli in patients with bacteremia. European Journal of Clinical Microbiology 1985, 4: 566–569.

    PubMed  Google Scholar 

  32. Svanbom M: A prospective study on septicemia. II: Clinical manifestations and complications, results of antimicrobial treatment and report of a follow-up study. Scandinavia Journal of Infectious Diseases 1980, 12: 189–206.

    Google Scholar 

  33. O'Brien TF: Members of task force 2. Resistance of bacteria to antibacterial agents: report of task force 2. Reviews of Infectious Diseases 1987, 9, Supplement 3: 244–260.

    Google Scholar 

  34. Julander I: Septicemia and endocarditis, 1965–1980, in a Swedish university hospital for infectious diseases. Infection 1987, 15: 177–183.

    Article  PubMed  Google Scholar 

  35. Cravioto A, Scotland SM, Rowe B: Haemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains ofEscherichia coli isolated from humans. Infection and Immunity 1982, 36: 189–197.

    PubMed  Google Scholar 

  36. Finlay BB, Falkow S: Common themes in microbial pathogenicity. Microbiological Reviews 1989, 53: 210–230.

    PubMed  Google Scholar 

  37. Martínez JC, Cercenado E, Pérez-Díaz JC, Baquero F: Multifactorial determination of systemic invasivity inEscherichia coli. FEMS Microbiology Letters 1986, 37: 259–261.

    Article  Google Scholar 

  38. Agüero ME, Cabello FC: Relative contribution of Col V plasmids and K1 antigen to the pathogenicity ofEscherichia coli. Infection and Immunity 1983, 40: 359–368.

    PubMed  Google Scholar 

  39. Korhonen TK, Valtonen MV, Parkinen J: Serotypes, hemolysin production and receptor recognition ofEscherichia coli strains associated with neonatal sepsis and meningitis. Infection and Immunity 1985, 48: 486–491.

    PubMed  Google Scholar 

  40. Montgomery JZ, Bindereif A, Neilands JB, Kalmanson GM, Guze LB: Association of hydroxamate siderophore withEscherichia coli isolated from patients with bacteremia. Infection and Immunity 1984, 46: 835–838.

    PubMed  Google Scholar 

  41. Johnson JR, Moseley SL, Roberts PL, Stamm WE: Aerobactin and other virulence factor genes among strains ofEscherichia coli causing urosepsis: association with patient characteristics. Infection and Immunity 1988, 56: 405–412.

    PubMed  Google Scholar 

  42. Carbonetti NH, Boonchai S, Parry SH, Väisänen-Rhen V, Korhonen TK, Williams PH: Aerobactin-mediated iron uptake byEscherichia coli isolates from human extraintestinal infections. Infection and Immunity 1986, 51: 966–968.

    PubMed  Google Scholar 

  43. Opal SM, Cross AS, Gemski P, Lythe LW: Aerobactin and α-hemolysin as virulence determinants inEscherichia coli isolated from human blood, urine, and stool. Journal of Infectious Diseases 1990, 161: 794–796.

    PubMed  Google Scholar 

  44. Smith HW, Huggins MB: Further observations on the association of the colicine V plasmid ofEscherichia coli with pathogenicity and with survival in the alimentary tract. Journal of General Microbiology 1976, 92: 335–350.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vázquez, F., Mendoza, M.C., Viejo, G. et al. Survey ofEscherichia coli septicemia over a six-year period. Eur. J. Clin. Microbiol. Infect. Dis. 11, 110–117 (1992). https://doi.org/10.1007/BF01967061

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967061

Keywords

Navigation